These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9238440)

  • 21. Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin.
    Lebeurier I; Basara N; Aïdoudi S; Amiral J; Caen JP; Han ZC
    Br J Haematol; 1996 Jan; 92(1):29-34. PubMed ID: 8562407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine-mediated erythroid maturation in megakaryoblastic human cell line HU-3.
    Morgan DA; Class R; Soslau G; Brodsky I
    Exp Hematol; 1997 Dec; 25(13):1378-85. PubMed ID: 9406997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance of CD34 expression during proliferation of CD34+ cord blood cells on glycosaminoglycan surfaces.
    Madihally SV; Flake AW; Matthew HW
    Stem Cells; 1999; 17(5):295-305. PubMed ID: 10527464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution.
    Bruno S; Gunetti M; Gammaitoni L; Danè A; Cavalloni G; Sanavio F; Fagioli F; Aglietta M; Piacibello W
    Haematologica; 2003 Apr; 88(4):379-87. PubMed ID: 12681964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
    Scheding S; Media JE; Nakeff A
    Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombopoietin and megakaryocyte differentiation].
    Vainchenker W; Debili N; Norol F; Wendling F
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1575-81. PubMed ID: 9824885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bioassay of recombinant human platelet factor 4].
    Han Z; Shen Q; Han Z
    Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):123-5. PubMed ID: 15622770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thrombopoietin is a multifunctional factor].
    Hino M
    Rinsho Byori; 1997 Oct; 45(10):921-6. PubMed ID: 9369068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologic role of TPO in thrombopoiesis.
    Miyazaki H
    Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
    Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
    Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
    Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
    Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.
    Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T
    Exp Hematol; 2008 Oct; 36(10):1337-42. PubMed ID: 18619724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo effects of KT6352, a derivative of indolocarbazole compounds, on murine megakaryocytopoiesis.
    Shiotsu Y; Akinaga S; Yamashita K; Murakata C; Tamaoki T; Ishida Y; Kuriya S; Teramura M; Mizoguchi H
    Exp Hematol; 1998 Dec; 26(13):1195-201. PubMed ID: 9845374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness.
    Mintern J; Williams N; Jackson H
    Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design.
    Cortin V; Garnier A; Pineault N; Lemieux R; Boyer L; Proulx C
    Exp Hematol; 2005 Oct; 33(10):1182-91. PubMed ID: 16219540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of cytokine interactions by flow cytometry and factorial analysis.
    Case J; Rice A; Wood J; Gaudry L; Vowels M; Nordon RE
    Cytometry; 2001 Jan; 43(1):69-81. PubMed ID: 11122486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ex vivo expansions of megakaryocytopoiesis from placental and umbilical cord blood CD34(+) cells in serum-free culture supplemented with proteoglycans extracted from the nasal cartilage of salmon heads and the nasal septum cartilage of whale.
    Kashiwakura I; Takahashi K; Monzen S; Nakamura T; Takagaki K
    Life Sci; 2008 May; 82(19-20):1023-31. PubMed ID: 18407295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.